10-Q – Page 142 – China Stock Advice

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2012 President and Chief Executive Officer EX-32.1 4 cphi10qex321093012.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2012 (principal financial officer and principal accounting officer) EX-32.2 5 cphi10qex322093012.htm]

By info| 2016-03-03T17:36:00+00:00 November 14th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2012-11-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2012

[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2012 President and Chief Executive Officer EX-32.1 4 cphi10qex321093012.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2012 (principal financial officer and principal accounting officer) EX-32.2 5 cphi10qex322093012.htm]

By info| 2016-03-03T17:37:37+00:00 November 14th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2012-11-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Weibing Lu, Chief Executive Officer] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Bing Mei, Chief Financial Officer]

By info| 2016-03-01T04:25:03+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2012-11-14, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Weibing Lu, Chief Executive Officer] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Bing Mei, Chief Financial Officer]

By info| 2016-03-01T04:25:47+00:00 November 14th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 10-Q, 2012-11-14, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

EGT [Entertainment Gaming Asia] 10-Q: (Original Filing)

[] [Section 302 Certification I, Clarence Chung, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER Section 302 Certification I, Andy Tsui, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Dated: November 14, 2012 Clarence Chung President and Chief Executive Officer Dated: November 14, 2012 Andy Tsui Chief Accounting Officer This certification is made solely for the purposes of 18 U.S.C. Section 1350, subject to the]

By info| 2016-03-13T23:56:04+00:00 November 14th, 2012|Categories: Chinese Stocks, EGT, SEC Original|Tags: 0001004673, 10-Q, 2012-11-14, 3990, EGT, MISCELLANEOUS MANUFACTURING INDUSTRIES|0 Comments

EGT [Entertainment Gaming Asia] 10-Q:

[] [Section 302 Certification I, Clarence Chung, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER Section 302 Certification I, Andy Tsui, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Dated: November 14, 2012 Clarence Chung President and Chief Executive Officer Dated: November 14, 2012 Andy Tsui Chief Accounting Officer This certification is made solely for the purposes of 18 U.S.C. Section 1350, subject to the]

By info| 2016-03-13T23:56:53+00:00 November 14th, 2012|Categories: Chinese Stocks, EGT, Webplus ver|Tags: 0001004673, 10-Q, 2012-11-14, 3990, EGT, MISCELLANEOUS MANUFACTURING INDUSTRIES|0 Comments

THTI [THT Heat Transfer Technology] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) [X] For the quarterly period ended: September 30, 2012 [ ] For the transition period from __________to______________ THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 20-5463509 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) THT Industrial Park No. 5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 Peoples Republic of China 86-434-3265241 (Former name,] [CERTIFICATIONS I, Guohong Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, ZhigangXu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial Officer)]

By info| 2016-03-22T17:57:39+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, THTI|Tags: 0001375686, 10-Q, 2012-11-14, 3443, FABRICATED PLATE WORK (BOILER SHOPS), THTI|0 Comments

THTI [THT Heat Transfer Technology] 10-Q: FORM 10-Q (Mark One) [X] For the quarterly

[FORM 10-Q (Mark One) [X] For the quarterly period ended: September 30, 2012 [ ] For the transition period from __________to______________ THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 20-5463509 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) THT Industrial Park No. 5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 Peoples Republic of China 86-434-3265241 (Former name,] [CERTIFICATIONS I, Guohong Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, ZhigangXu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial Officer)]

By info| 2016-03-22T17:58:36+00:00 November 14th, 2012|Categories: Chinese Stocks, THTI, Webplus ver|Tags: 0001375686, 10-Q, 2012-11-14, 3443, FABRICATED PLATE WORK (BOILER SHOPS), THTI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of September 30, 2012 (Unaudited) and December 31, 2011 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months and Nine Months Ended September 30, 2012 and 2011 (Unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Weibing Lu, Chief Executive Officer v327445_ex32-1.htm 4 EX-32.1] [(2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Bing Mei, Chief Financial Officer v327445_ex32-2.htm 5 EX-32.2]

By info| 2016-02-05T03:02:29+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2012-11-14, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended September 30, 2012 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer, Chief Accounting Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Director]

By info| 2016-03-27T18:59:55+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 10-Q, 2012-11-14, 2834, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments